EUCTR2004-005159-32-IT进行中（未招募）不适用
INEZOLID VS VANCOMYCIN/CEFAZOLIN IN THE TREATMENT OF HEMODIALYSIS PATIENTS WITH CATHETER-RELATED GRAM-POSITIVE BLOODSTREAM INFECTIONS.
PHARMACIA UPJOH0 个研究点开始时间: 2005年9月21日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-DEPfizer Pharma GmbH332
进行中（未招募）
1 期
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/ACatheter-related Gram-positive bloodstream infections.MedDRA version: 7.1Level: LLTClassification code 10007810EUCTR2004-005159-32-SKPfizer Limited322
进行中（未招募）
1 期
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-ESPfizer, S.A332
未知
不适用
inezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections-T802 Infections following infusion, transfusion and therapeutic injectionInfections following infusion, transfusion and therapeutic injectionT802PER-033-05PFIZER S.A.,
已完成
不适用
INEZOLID IV / ORAL VS VANCOMYCIN IV IN THE TREATMENT OF RESISTANT GRAM POSITIVE BACTERIAL INFECTIONS IN CHILDRE-A49 Bacterial infection of unspecified siteBacterial infection of unspecified siteA49PER-015-01PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,